Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review-Reference-Cited by-同舟云学术

Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review

Published:2022-06-14 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Aziz Syed N,Proano Lucia,Cruz Claudio,Tenemaza Maria Gabriela,Monteros Gustavo,Hassen Gashaw,Baskar Aakash,Argudo Jennifer M,Duenas Jonathan B,Fabara Stephanie P

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference20 articles.

1. Erdheim-Chester disease;Haroche J;Blood,2020

2. Erdheim-Chester disease: a concise review;Papo M;Curr Rheumatol Rep,2019

3. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease;Cangi MG;Ann Rheum Dis,2015

4. Erdheim-Chester disease: characteristics and management;Munoz J;Mayo Clin Proc,2014

5. Erdheim-Chester disease;Starkebaum G;Best Pract Res Clin Rheumatol,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erdheim–Chester Disease With MAP2K (p.K57N) Mutation Diagnosed With Kidney Biopsy;Annals of Internal Medicine: Clinical Cases;2024-08-01

2. Advances in Understanding and Management of Erdheim-Chester Disease;Life Sciences;2024-07

3. Pericardial Effusion and Tamponade as the Manifestation of Erdheim–Chester Disease;Annals of Internal Medicine: Clinical Cases;2024-04-01

4. Erdheim–Chester Disease: Investigating the Correlation between Targeted Treatment Therapy and Disease Outcomes;Cancers;2024-03-27

5. Pericardiectomy and Mechanical Mitro-Aortic Valve Replacement in a Young Patient With Erdheim-Chester Disease;Texas Heart Institute Journal;2024-02-07